Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

[C-Reactive protein levels in patients with chronic obstructive pulmonary disease].

Díaz O, Parada A, Ramos C, Klaassen J, Díaz JC, Andresen M, Lisboa C, Saldías F.

Rev Med Chil. 2012 May;140(5):569-78. doi: 10.4067/S0034-98872012000500003. Spanish.

2.

[Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].

Morales S A, Dreyse D J, Díaz P O, Saldías P F, Carrasco M, Lisboa B C.

Rev Med Chil. 2010 Aug;138(8):957-64. doi: /S0034-98872010000800003. Epub 2010 Nov 26. Spanish.

3.

C-reactive protein in patients with COPD, control smokers and non-smokers.

Pinto-Plata VM, Müllerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, Celli BR.

Thorax. 2006 Jan;61(1):23-8. Epub 2005 Sep 2.

4.

Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.

de Moraes MR, da Costa AC, Corrêa Kde S, Junqueira-Kipnis AP, Rabahi MF.

Int J Chron Obstruct Pulmon Dis. 2014 Jul 29;9:735-43. doi: 10.2147/COPD.S64135. eCollection 2014.

5.

C-reactive protein levels and clinically important predictive outcomes in stable COPD patients.

de Torres JP, Cordoba-Lanus E, López-Aguilar C, Muros de Fuentes M, Montejo de Garcini A, Aguirre-Jaime A, Celli BR, Casanova C.

Eur Respir J. 2006 May;27(5):902-7. Epub 2006 Feb 2.

6.

Associations between BODE index and systemic inflammatory biomarkers in COPD.

Gaki E, Kontogianni K, Papaioannou AI, Bakakos P, Gourgoulianis KI, Kostikas K, Alchanatis M, Papiris S, Loukides S.

COPD. 2011 Dec;8(6):408-13. doi: 10.3109/15412555.2011.619599.

PMID:
22149400
7.

[C-reactive protein levels in patients with chronic obstructive pulmonary disease and asthma].

Urboniene D, Sakalauskas R, Sitkauskiene B.

Medicina (Kaunas). 2008;44(11):833-40. Lithuanian.

8.

Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.

Valipour A, Schreder M, Wolzt M, Saliba S, Kapiotis S, Eickhoff P, Burghuber OC.

Clin Sci (Lond). 2008 Oct;115(7):225-32. doi: 10.1042/CS20070382.

PMID:
18307413
9.

Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease.

van den Borst B, Gosker HR, Wesseling G, de Jager W, Hellwig VA, Snepvangers FJ, Schols AM.

Am J Clin Nutr. 2011 Dec;94(6):1504-12. doi: 10.3945/ajcn.111.023911. Epub 2011 Nov 9.

10.

Relationship between serum cardiac troponin T level and cardiopulmonary function in stable chronic obstructive pulmonary disease.

Hattori K, Ishii T, Motegi T, Kusunoki Y, Gemma A, Kida K.

Int J Chron Obstruct Pulmon Dis. 2015 Feb 10;10:309-20. doi: 10.2147/COPD.S76293. eCollection 2015.

11.

The role of small heat-shock protein αB-crystalline (HspB5) in COPD pathogenesis.

Cherneva RV, Georgiev OB, Petrova DS, Trifonova NL, Stamenova M, Ivanova V, Vlasov VI.

Int J Chron Obstruct Pulmon Dis. 2012;7:633-40. doi: 10.2147/COPD.S34929. Epub 2012 Oct 4.

12.

Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.

Karadag F, Karul AB, Cildag O, Yilmaz M, Ozcan H.

Lung. 2008 Nov-Dec;186(6):403-9. doi: 10.1007/s00408-008-9106-6. Epub 2008 Sep 20.

PMID:
18807087
13.

Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.

Thomsen M, Ingebrigtsen TS, Marott JL, Dahl M, Lange P, Vestbo J, Nordestgaard BG.

JAMA. 2013 Jun 12;309(22):2353-61. doi: 10.1001/jama.2013.5732.

PMID:
23757083
14.

Correlation between serum biomarkers and BODE index in patients with stable COPD.

Liu SF, Chin CH, Wang CC, Lin MC.

Respirology. 2009 Sep;14(7):999-1004. doi: 10.1111/j.1440-1843.2009.01608.x.

PMID:
19740260
15.

Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study.

Eagan TM, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Damås JK, Aukrust P, Bakke PS.

Eur Respir J. 2010 Mar;35(3):540-8. doi: 10.1183/09031936.00088209. Epub 2009 Jul 30.

16.

Bronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly. The Tromsø Study 2001.

Melbye H, Halvorsen DS, Hartz I, Medbø A, Brox J, Eggen AE, Njølstad I.

Respir Med. 2007 Dec;101(12):2541-9. Epub 2007 Sep 6.

17.

Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.

Gatta D, Aliprandi G, Pini L, Zanardini A, Fredi M, Tantucci C.

Eur Rev Med Pharmacol Sci. 2011 Sep;15(9):1068-73.

PMID:
22013730
18.

Circulating visfatin in chronic obstructive pulmonary disease.

Liu X, Ji Y, Chen J, Li S, Luo F.

Nutrition. 2009 Apr;25(4):373-8. doi: 10.1016/j.nut.2008.09.008. Epub 2008 Dec 4.

PMID:
19056239
19.

[Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].

Saldías PF, Díaz PO, Dreyse DJ, Gaggero BA, Sandoval AC, Lisboa BC.

Rev Med Chil. 2012 Jan;140(1):10-8. doi: /S0034-98872012000100002. Epub 2012 Apr 12. Spanish.

20.

Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters.

Calikoglu M, Sahin G, Unlu A, Ozturk C, Tamer L, Ercan B, Kanik A, Atik U.

Respiration. 2004 Jan-Feb;71(1):45-50.

PMID:
14872110

Supplemental Content

Support Center